Table 2 Bone disease management and systemic treatment
From: Inaugural bone metastases in non-small cell lung cancer: a specific prognostic entity?
Therapeutic on first SRE | n - % |
|---|---|
Radiotherapy | 38 - 70.4% |
Surgery followed by radiotherapy | 9 - 14.8% |
Percutaneous vertebroplasty/Medical treatments | 2/6 - 14.8% |
Biphosphonates | 33 - 60% |
Systemic treatment | |
First line chemotherapy | 53 - 96% |
Second line chemotherapy | 31 - 56% |